Instabile Angina pectoris: Pathogenese, Risikostratifizierung und Therapie

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 10, 1996, Pages 310-317

  Schoebel, F C ^a   Stein, D ^a   Borries, M ^a   Heins, M ^b   Heintzen, M P ^a   Leschke, M ^a   Strauer, B E ^a  

^a Medizinische Klinik und Poliklinik   (Germany)

^b Inst F Klin Chem L   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN; HEPARIN;

CORONARY ARTERY ATHEROSCLEROSIS; HEART FUNCTION TEST; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; CORONARY ARTERY DISEASE; INTRAVENOUS DRUG ADMINISTRATION; PATHOGENESIS; RISK ASSESSMENT;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ARTERIOSCLEROSIS; FIBRINOLYTIC AGENTS; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS;

EID: 0030574763     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043007     Document Type: Article

References (63)

1. Bär, F. W., F. W. Verbeugt, J. Col, P. Matere, J. P. Monassier, P. G. Ceslin, J. Metzger, P. Raynaud, J. Foucault, C. De Zwaan, F. Vermeer: Thrombolysis in patients with unstable angina improves angiographic but not clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation 86 (1992), 131-137.
2. Borries, M., M. Heins, Y. Fischer, H. Stiegler, F. C. Schoebel, H. Reinauer, M. Leschke, B. E. Strauer: Endothelin bei koronarer Herzkrankheit. Z. Kardiol. 84, Suppl. 1 (1995), 49.
3. Bosch, X., P. Theroux, G. B. Pelletier, G. Sanz, D. Roy, D. Waters: Clinical and angiographic features and prognostic significancy of early postinfarction angina with and without electrocardiographic signs of transient ischemia. Amer. J. Med. 91 (1991), 493-501.
4. Braunwald, E.: Unstable angina. A classification. Circulation 80 (1989), 410-414.
5. Braunwald, E., D. B. Mark, R. H. Jones, M. D. Cheitlin, V. Fuster, K. M. McCauley, C. Edwards, L. A. Green, A. I. Mushlin, J. A. Swain, E. E. Smith III, M. Cowan, G. C. Rose, C. A. Concannon, C. L. Grines, L. Brown, B. W. Lytle, L. Goldman, E. J. Topol, J. T. Willerson, J. Brown, N. Archibald: Unstable angina. Diagnosis and management. Clinical practice guideline 10 - AHCPR - publication No. 94 - 0602 (U.S. Department of Health and Human Services: Rockville 1994).
6. Burlina, A., M. Zaninotto, S. Secchiero, D. Rubin, F. Accrosi: Troponin T as a marker of ischemic injury. Clin. Biochem. 27 (1994), 113-121.
7. Cairns, J. A., M. Gent, J. Singer, K. J. Finnis, G. M. Frogatt, D. A. Holder, G. Jablonsky, W. J. Kostok, L. J. Melendez, M. G. Myers: Aspirin, sulfinpyrazone, or both in unstable angina. New Engl. J. Med. 313 (1985), 1369-1375.
8. Cohen, M., P. C. Adams, K. Parry, J. Xiong, D. Chamberlain, I. Wieczorek, K. A. Fox, J. H. Chesebro, J. Strain, C. Keller, A. Kelly, G. Lancaster, J. Ali Kronmal, V. Fuster: Antithrombotic Therapy in Acute Coronary Syndromes Research Group: Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Circulation 89 (1994), 81-88.
9. Duncan, B., M. Fulton, S. L. Morrison, W. Lutz, K. W. Donald, F. Kerr, B. J. Kirby, D. G. Julian, M. F. Oliver: Prognosis of new and worsening angina pectoris. Brit. med. J. 1976/I, 981-985.
10. Falk, E.: Unstable angina with fatal outcome. Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71 (1985), 699-708.
11. Falk, E., P. K. Shah, V. Fuster: Coronary plaque disruption. Circulation 92 (1995), 657-671.
12. Freeman, M. R., A. Langer, R. F. Wilson, C. D. Morgan, P. W. Armstrong: Thrombolysis in unstable angina. A randomized double-blind trial of t-PA and placebo. Circulation 85 (1992), 150-157.
13. Fuster, V., L. Badimon, J. Badimon, J. Chesebro: The pathogenesis of coronary artery disease and the acute coronary syndromes. First of two parts. New Engl. J. Med. 326 (1992), 242-250.
14. Fuster, V., L. Badimon, J. Badimon, J. Chesebro: The pathogenesis of coronary artery disease and the acute coronary syndromes. Second of two parts. New Engl. J. Med. 326 (1992), 242-250.
15. Görge, G., M. Haude, C. von Birgelen, G. Caspari, R. Erbel: Reperfusionstherapie bei akutem Myokardinfarkt. Dtsch. med. Wschr. 120 (1995), 375-382.
16. Goldman, L., E. F. Cook, D. A. Brand, T. H. Lee, G. W. Rouan, M. Weisberg, D. Acampora, C. Stasiulewicz, J. Walshon, G. Terranova, L. Gottlieb, M. Kobernick, B. Goldstein-Wayne, D. Copen, K. Daley, A. A. Brandt, D. Jones, J. Mellors, R. Jakubowski: A computer protocol to predict myocardial infarction in emergency department patients with chest pain. New Engl. J. Med. 318 (1988), 797-803.
17. Gotto, A.: Lipid lowering, regression and coronary events. A review of the interdiciplinary council on lipids and cardiovascular risk intervention. Seventh council meeting. Circulation 92 (1995), 646-656.
18. Granger, C. B., J. M. Miller, E. G. Bovill, A. Gruber, R. P. Tracy, M. W. Krucoff, C. Green, E. Berrios, R. A. Harrington, E. M. Ohman, R. M. Califf: Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91 (1995), 1929-1935.
19. Hamm, C. W., R. Lorenz, W. Bleifeld, W. Küpper, W. Wober, P. Weber: Biochemical evidence of platelet activation in patients with persistent unstable angina. J. Amer. Coll. Cardiol. 10 (1987), 998-1004.
20. Hamm, C. W., J. Ravkilde, W. Gerhardt, P. Jørgensen, E. Peheim, L. Ljundahl, B. Golmann, H. A. Katus: The prognostic value of serum troponin T in unstable angina. New Engl. J. Med. 327 (1992), 146-150.
21. Heintzen, M. P., B. E. Strauer: Interventionelle Strategien bei kritischen Situationen der koronaren Herzkrankheit. Intensivmed. 31 (1994), 277-287.
22. Johnson, P. H.: Hirudin. Clinical potential of a thrombin inhibitor. Ann. Rev. Med. 45 (1994), 165-177.
23. Kamp, O., K. J. Beatt, P. J. de Feyter, M. van den Brand, Surayapranata, H. E. Luijten, P. W. Serruys: Short-, medium-, and long-term follow-up after percutaneous transluminal angioplasty for stable and unstable angina pectoris. Amer. Heart J. 117 (1989), 991-996.
24. Karlson, B. W., J. Herlitz, P. Petterson, P. Hallgren, U. Stromborn, A. Hjalmarson: One-year prognosis in patients hospitalized with a history of unstable angina pectoris. Clin. Cardiol. 16 (1993), 397-402.
25. Katus, H. A., A. Remppis, F. J. Neumann, T. Scheffold, K. W. Diederich, G. Vinar, A. Noe, G. Gatern, W. Kübler: Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83 (1991), 902-912.
26. Koenig, W., E. Ernst: The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 94 (1992), 93-107.
27. Kurz, T., B. Rauch, W. Kübler: Antianginöse Therapie der koronaren Herzerkrankung. Mono- und Kombinationsbehandlung. Z. Kardiol. 80 (1991), 305-316.
28. Lee, H. L., G. Juarez, E. F. Cook, M. C. Weisberg, G. W. Rouan, D. A. Brand, L. Goldman: Ruling out myocardial infarction. A prospective mulitcenter validation of a 12-hour strategy for patients at low risk. New Engl. J. Med. 324 (1991), 1239-1246.
29. Leschke, M., H. Blanke, M. Stellwaag, W. Motz, B. E. Strauer: Hyperfibrinogenämie und pathologische Plasmaviskosität. Pathogenetische Faktoren bei der instabilen Angina pectoris? Dtsch. med. Wschr. 113 (1988), 1175-1181.
30. Leschke, M., F. C. Schoebel, W. Mecklenbeck, D. Stein, T. W. Jax, H. W. Müller-Gärtner, B. E. Strauer: Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris. A randomized dose-response trial. J. Amer. Coll. Cardiol. (1996), in press.
31. Levkovits, J., E. F. Plow, E. J. Topol: Platelet glycoprotein IIb/IIIa receptors in cardiovascular disease. New Engl. J. Med. 332 (1995), 1533-1559.
32. Lewis, H. D., J. W. Davies, D. G. Archibald, W. E. Steinke, T. C. Smitherman, J. E. Doherty, H. M. Schnaper, M. M. Iewinter, E. Lineres, J. M. Pouget, S. C. Sabharwal, E. Chesler, DeMots: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. New Engl. J. Med. 309 (1983), 396-403.
33. Liuzzo, G., L. M. Biasucci, R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, A. Maseri: The prognostic value of C-reactive protein and amyloid A protein in severe unstable angina. New Engl. J. Med. 331 (1994), 417-424.
34. MacIsaac, A. I., J. D. Thomas, E. J. Topol: Toward the quiescent coronary plaque. J. Amer. Coll. Cardiol. 22 (1993), 1228-1241.
35. Mark, D. B., C. L. Nelson, R. M. Califf, F. E. Harrell, K. L. Lee, R. H. Jones, D. F. Fortin, R. S. Stack, D. D. Glower, R. Smith, E. R. DeLong, P. K. Smith, J. G. Reves, J. G. Jollis, T. E. Tcheng, L. H. Muhlbaier, J. E. Lowe, H. R. Phillips, D. B. Pryor: Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 89 (1994), 2015-2025.
36. Maseri, A., A. L. Abbate, G. Baroldi, S. Chierchia, M. Marzilli, M. Ballestra, S. Severi, O. Parodi, A. Biagini, A. Distante, A. Pesola: Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from »pretnfarction« angina. New Engl. J. Med. 299 (1978), 1271-1277.
37. Miche, E., D. Baller, U. Gleichmann, H. Mannebach, H. Schmidt, W. Prohaska: Fibrinogen und Leukozytenzahl bei koronarer Herzkrankheit. Korrelation zum angiokardiographischen und klinischen Schweregrad. Z. Kardiol. 84 (1995), 92-98.
38. Mizuno, K., A. Miyamoto, K. Satomura, A. Kurita, T. Arai, S. Masami, S. Yanagida, H. Nakamura: Angioscopic coronary morphology in acute coronary disorders. Lancet 337 (1991), 809-812.
39. Morrison, D. A., C. Barbierre, A. Cohan, M. A. Olsen, R. Stovall, D. Wolff: Coronary angioplasty for medically refractory unstable angina within 30 days of acute myocardial infarction. Amer. Heart J. 120 (1990), 256-261.
40. Motz, W., M. Kelm, B. Schwartzkopff, B. E. Strauer: Angina pectoris bei arterieller Hypertonie und normalem Koronarangiogramm. Dtsch. med. Wschr. 119 (1994), 593-595.
41. Muller, J. E., G. H. Tofler, P. H. Stone: Circadian triggers of onset of acute cardiovascular disease. Circulation 79 (1989), 733-743.
42. Myler, R. K., R. E. Shaw, S. H. Stertzer, T. T. Bashour, C. Ryan, H. S. Hecht, D. C. Cumberland: Unstable angina and coronary angioplasty. Circulation 82, Suppl. II (1990), 88-95.
43. Nattel, S., W. Warnica, R. I. Ogilvie: Indications for admission to a coronary care unit in patients with unstable angina. Canad. med. Ass. J. 122 (1980), 180-184.
44. Ravkilde, J., M. Hørder, W. Gerhardt, L. Ljungdahl, T. Petterson, N. Tryding, B. H. Møller, A. Hamfeldt, T. Graven, A. Asberg, M. Helin, I. Pentillä, K. Thygesen: Diagnostic performance and prognostic value of serum troponin T in suspected myocardial infarction. Scand. J. clin. Lab. Invest. 53 (1993), 677-685.
45. Romeo, F., G. M. C. Rosano, E. Martuscelli, M. Comito, N. Cardona, C. Colistra, B. Milano, C. Bianco, V. Rosano: Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina. J. Amer. Coll. Cardiol. 25 (1995), 1295-1299.
46. Rupprecht, H. J., R. Brennecke, M. Kottmeyer, G. Bernhard, R. Erbel, T. Pop, J. Meyer: Short- and long-term outcome after PTCA in patients with stable and unstable angina pectoris. Europ. Heart J. 11 (1990), 964-973.
47. Scheffold, T., J. Zehelein, M. Müller-Bardorf, H. A. Katus: Ischämie-monitoring mit neuen Markern. Z. Kardiol. 83, Suppl. 6 (1994), 74-82.
48. Schoebel, F. C., M. Leschke, B. E. Strauer: Therapierefraktäre Angina pectoris. Pathophysiologische Grundlagen und alternative Therapieansätze. Dtsch. med. Wschr. 120 (1995), 301-307.
49. Schoebel, F. C., T. W. Jax, M. Leschke, B. E. Strauer: Therapierefraktäre Angina pectoris bei koronarer Herzkrankheit. Ein Koronarsyndrom mit intensivmedizinischer Bedeutung. Intensivmed. 32 (1995), 552-559.
50. Schoebel, F. C., D. Stein, M. Heins, M. P. Heintzen, M. Leschke, B. E. Strauer: Systemische Thrombolyse bei instabiler Angina pectoris. Neue Aspekte bei therapierefraktären Patienten. Perfusion 8 (1995), 324-330.
51. Schreiber, T. L., D. Rizik, C. White, G. V. R. Sharma, M. Cowley, G. Macina, P. S. Reddy, L. Kantounis, G. C. Timmis, A. Margulis, P. Bunnell, W. Barker, A. Sasahara: Randomized trial of thrombolysis versus heparin in unstable angina. Circulation 86 (1992), 1642-1644.
52. Stein, D., M. Heins, F. C. Schoebel, W. Withold, M. Friebe, T. W. Jax, H. Reinauer, M. Leschke, B. E. Strauer: Aktivierung des fibrinolytischen Systems bei Hyperfibrinogenämie und koronarer Herzkrankheit. Z. Kardiol. 84, Suppl. 1 (1995), 224.
53. Strauer, B. E.: The significance of coronary reserve in clinical heart disease. J. Amer. Coll. Cardiol. 15 (1990), 775-783.
54. The RISC Group: Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 336 (1990), 827-830.
55. Theroux, P., H. Quimet, J. McCans, J. G. Latour, P. Joly, G. Levy, E. Pelletier, M. Juneau, J. Stasiak, P. de Guise, G. B. Pelletier, D. Rinzler, D. D. Waters: Aspirin, heparin, or both to treat acute unstable angina. New Engl. J. Med. 319 (1988), 1105-1111.
56. Theroux, P., D. Waters, S. Qiu, J. McCans, P. de Guise, M. Juneau: Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 88 (1993), 2045-2048.
57. The TIMI IIIb Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results from the TIMI IIIb trial. Circulation 89 (1994), 1545-1556.
58. Thompson, S. G., J. Kienast, S. D. M. Pyke, F. Haverkate, J. C. W. van de Loo, European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl. J. Med. 332 (1995), 635-641.
59. Topol, E. J., V. Fuster, R. A. Harrington, R. M. Califf, N. S. Kleinman, D. J. Kereiakes, M. Cohen, A. Chapekis, H. K. Gold, M. A. Tannenbaum, A. K. Rao, D. Debowey, D. Schwartz, M. Henis, J. Chesebro: Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. Circulation 89 (1994), 1557-1566.
60. van de Wal, C. A., A. C. Backer, C. M. van der Loos, P. K. Das: Site of intimai rupture or erosion of thrombosed coronary athersclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994), 36-44.
61. White, L. D., T. H. Lee, E. F. Cook, M. C. Weisberg, G. W. Rouan, D. A. Brand, L. Goldman, Chest Pain Study Group: Comparison of the natural history of new onset and exacerbated chronic ischemic heart disease. J. Amer. Coll. Cardiol. 16 (1990), 304-310.
62. Willerson, J. T., P. Golino, J. Eidt, W. B. Campbell, L. M. Buja: Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 80 (1989), 198-205.
63. Zeiher, A. M., H. Goebel, V. Schächinger, C. Ihling: Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91 (1995), 941-947.